ARCHIVES

IDMC Halts Mekinist-Tafinlar Trial Early Due to OS Benefit; Recommends Crossover

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

Intercultural Cancer Council Endorses New NCI Office

July 5, 1996

Paul Goss, Patricia Ganz Discuss Breast Cancer Prevention Trials.

April 20, 2007

Obituary: Patricia Delaney, FDA Cancer Liaison.

June 6, 2008

NCI, IOM Called To Congress to Explain Divergent Positions On Minority Research

January 29, 1999

ODAC Reviews Post-Marketing Studies for Eight Indications

February 21, 2003

The March To Deliver Message Of Funding For Cancer Research, Access To Care

September 4, 1998